Login / Signup

The efficacy of colchicine as an adjunct therapy in non-hospitalized COVID-19 patients: A randomized placebo-controlled trial.

Sepideh HejaziZohreh JahaniSepideh ElyasiDavoud SalarbashiMona Kabiri
Published in: Recent advances in anti-infective drug discovery (2023)
Our findings revealed that colchicine adjuvant therapy had no beneficial effect on clinical and para-clinical parameters in non-hospitalized COVID-19 patients during 14 days of intervention. The present trial does not support colchicine as a potential treatment against COVID-19 disease.
Keyphrases
  • sars cov
  • study protocol
  • coronavirus disease
  • randomized controlled trial
  • clinical trial
  • single cell
  • stem cells
  • phase iii
  • phase ii
  • respiratory syndrome coronavirus
  • mesenchymal stem cells
  • cell therapy